Blood And Tears in Alzheimer's Disease
Recruiting now
Conditions studied: Neurodegenerative Diseases
In brief
This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.
Key facts
- Study ID
- NCT06567431
- Run by
- Danish Dementia Research Centre
- People needed
- 600
- Starts
- 2024-03-18
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2024-08-22
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Inclusion criteria for patients:
- Lumbar puncture with CSF avaiable for analysis
- Diagnosis of Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), vascular dementia (VaD) or Normal pressure hydrocephalus (NPH)
- Of legal age.
- Inclusion criteria for controls:
- Lumbar puncture with CSF avaiable for analysis
- No neurological disease.
- Of legal age.
You may not qualify if…
- No lumbar puncture
- Clinically assessed as unfit to participate in the project.
Where it is running
- Danish Dementia Research Centre — Copenhagen, Denmark (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.